BridgeMD
New treatment option for Breast Cancer Patients
Official title The Effect of Cold Salt Water Foot Bath on the Development Of Chemotherapy-Induced Peripheral Neuropathy
ClinicalTrials.gov ID: NCT06964802
What this study is testing
- What it's testing
- This prospective, randomised, controlled study was designed to evaluate the effectiveness of salt and unsalted cold water foot baths in preventing chemotherapy-induced peripheral neuropathy (CIPN) in patients receiving paclitaxel. The study's sub-objectives were to minimise the development of CIPN, reduce its severity and incidence of symptoms, and minimise its impact on daily life and activities.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Women aged 18 and over.
- Conscious
- Speaking and understanding Turkish
- The diagnosis was breast cancer
- Those who will receive paclitaxel chemotherapy
You likely can't join if
- Responding to the vibration test (if the practitioner does not feel the vibration when the patient says they feel the vibration, it means that...
- Feeling pressure in one or none of the three areas on the plantar surface of the foot according to the monofilament test
- Previous chemotherapy-associated peripheral neuropathy
- Diagnosed with diabetes
- Open wounds or skin ulcers on the foot
- With peripheral and central nervous system disease
See the full eligibility criteria
- Women aged 18 and over.
- Conscious
- Speaking and understanding Turkish
- The diagnosis was breast cancer
- Those who will receive paclitaxel chemotherapy
- These are patients who answered 'no' to the 'A' section of the CIPNAT scale
- Responding to the vibration test (if the practitioner does not feel the vibration when the patient says they feel the vibration, it means that neuropathy is present)
- Feeling pressure in one or none of the three areas on the plantar surface of the foot according to the monofilament test
- Previous chemotherapy-associated peripheral neuropathy
- Diagnosed with diabetes
- Open wounds or skin ulcers on the foot
- With peripheral and central nervous system disease
- Peripheral vascular disease,
- Patients with bone or soft tissue metastases
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Uskudar, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Uskudar, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.